Good morning :)
Switch to
Place Order

Lyka Labs Ltd

LYKALABS
Health CarePharmaceuticals
SmallcapWith a market cap of ₹340 cr, stock is ranked 1,454
High RiskStock is 3.48x as volatile as Nifty
118.650.17% (+0.20)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹340 cr, stock is ranked 1,454
High RiskStock is 3.48x as volatile as Nifty

Key Metrics

PE RatioPE RatioPB RatioPB RatioDividend YieldDiv. Yield
8.7323.85
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
38.164.820.92%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Lyka Labs Limited is a pharmaceutical products and services provider. The Company is primarily engaged in formulation and manufacturing lyophilized products.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Financial TrendFinancial statements 

2019202020212022+72.87+66.33+87.81+196.17-5.56-60.54-11.55+39.00
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Increased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has increased by 27.75%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Increased Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has increased by 2.81%

See detailed holdings

Recent EventsAll events 

Clarification 
Announced OnAug 11, 2022
The Exchange has sought clarification from Lyka Labs Limited with respect to announcement dated 09-Aug-2022 informing about Appointment of Director.On the basis of aforesaid announcement, the Company is required to provide/clarify the following: 1. Disclosure of relationships between directors (in case of appointment of a directors) 2. Brief profile (in case of appointment) 3. Confirmation from Director that there are no material reasons for resignation other than that disclosed 4. Affirmation that the Director being appointed is not debarred from holding the office of director by virtue of any SEBI order or any other such authority The response of the company is awaited.
The Exchange has sought clarification from Lyka Labs Limited with respect to announcement dated 09-Aug-2022 informing about Appointment of Director.On the basis of aforesaid announcement, the Company is required to provide/clarify the following: 1. Disclosure of relationships between directors (in case of appointment of a directors) 2. Brief profile (in case of appointment) 3. Confirmation from Director that there are no material reasons for resignation other than that disclosed 4. Affirmation that the Director being appointed is not debarred from holding the office of director by virtue of any SEBI order or any other such authority The response of the company is awaited.
General updates 
Announced OnAug 9, 2022

Dear Sir,We are seeking approval of the shareholders through e-postal ballot voting for following business.1. Appointment of Mr. Prashant Godha an Additional Director as a Director of the Company. 2. Appointment of Mr. Shashil Mendonsa an Additional Director as a Director of the Company. 3. Appointment of Mr. Babulal Jain as an Independent Director of the Company for a term of five years w.e.f. 8th August, 2022.Calendar of Events for e-postal ballot notice and e-voting attached. | Download

Dear Sir,We are seeking approval of the shareholders through e-postal ballot voting for following business.1. Appointment of Mr. Prashant Godha an Additional Director as a Director of the Company. 2. Appointment of Mr. Shashil Mendonsa an Additional Director as a Director of the Company. 3. Appointment of Mr. Babulal Jain as an Independent Director of the Company for a term of five years w.e.f. 8th August, 2022.Calendar of Events for e-postal ballot notice and e-voting attached. | Download

General updates 
Announced OnAug 9, 2022

Lyka Labs Limited has informed the Exchange about Intimation of Reconstitution of Audit Committee, Nomination & Remuneration Committee, Stakeholders Relationship Committee, Risk Management Committee and Corporate Social Responsibility (CSR) Committee under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 | Download

Lyka Labs Limited has informed the Exchange about Intimation of Reconstitution of Audit Committee, Nomination & Remuneration Committee, Stakeholders Relationship Committee, Risk Management Committee and Corporate Social Responsibility (CSR) Committee under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 | Download

See all events